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The resurrection of pseudogenes during evolution produced lncRNAs with new biological
function. Here we show that pseudogene-evolution created an Oct4 pseudogene lncRNA that
is able to direct epigenetic silencing of the parental Oct4 gene via a 2-step, lncRNA dependent
mechanism. The murine Oct4 pseudogene 4 (mOct4P4) lncRNA recruits the RNA binding
protein FUS to allow the binding of the SUV39H1 HMTase to a defined mOct4P4 lncRNA
sequence element. The mOct4P4-FUS-SUV39H1 silencing complex holds target site specifi-
city for the parental Oct4 promoter and interference with individual components results in
loss of Oct4 silencing. SUV39H1 and FUS do not bind parental Oct4 mRNA, confirming the
acquisition of a new biological function by the mOct4P4 lncRNA. Importantly, all features of
mOct4P4 function are recapitulated by the human hOCT4P3 pseudogene lncRNA, indicating
evolutionary conservation. Our data highlight the biological relevance of rapidly evolving
lncRNAs that infiltrate into central epigenetic regulatory circuits in vertebrate cells.
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Pseudogenes are non-functional gene copies that have lostprotein coding potential. Precise annotation and integrationof functional genomics data revealed a high number of
pseudogenes that have evolved to new functional elements, pro-
ducing long noncoding RNAs (lncRNAs) in a tightly controlled
manner1,2. In many cases, sequence similarity of pseudogene
derived lncRNAs with parental gene transcripts provides the
rational basis for pseudogene dependent control of ancestral gene
expression. Pseudogene lncRNAs have been reported to compete
with parental gene transcripts for miRNAs or RNA binding
proteins or, alternatively, can give rise to endo-siRNAs3–8.
Antisense transcription of pseudogenes can mediate epigenetic
silencing of ancestral genes in trans, presumably by pairing with
ancestral sense gene transcripts9,10. Remarkably, pseudogene
derived lncRNAs have also been demonstrated to act as scaffold
for chromatin modifying complexes that can modulate gene
expression at multiple loci across the genome11,12.
The transcription factor OCT4 is central for vertebrate
embryonic stem cell (ESC) pluripotency and cancer cell biology
and represents a hallmark model for the multifaceted pathways
of pseudogene lncRNA mediated regulation of parental gene
expression10,13–23. During evolution, the murine and human
Pou5f1/POU5F1 genes, that encode OCT4, gave rise to five
processed murine (Pou5F1P1–Pou5F1P5) and eight processed
human pseudogenes (POU5F1P1–POU5F1P8), with validated
lncRNA expression17,24–26. Hereinafter, Pou5f1 and POU5F1
pseudogenes will be referred to as Oct4/OCT4 pseudogenes.
Murine Oct4 pseudogene derived lncRNAs show defined pat-
tern of expression during mouse embryonic stem cells (mESC)
differentiation and specific cytoplasmic or nuclear localization,
supporting evidence for the acquisition of new biological
function17. In line with this, human OCT4 pseudogene 4 and 5
lncRNAs alter ancestral gene expression by acting as classic
ceRNAs, and pairing of the murine Oct4-pseudogene 5 anti-
sense lncRNA with Oct4 transcripts has a role in guiding the
histone methyltransferase (HMTase) EZH2 to the OCT4
promoter10,16,27.
We recently reported on a new mechanism of ancestral gene
regulation that depends on pseudogene lncRNA dependent
recruitment of an epigenetic silencing complex to the Oct4 pro-
moter in trans17. Induction of mESC differentiation results in
efficient upregulation of the X-linked mOct4P4 gene that encodes
the mOct4P4 lncRNA. The resulting nuclear restricted mOct4P4
lncRNA forms a complex with the HMTase SUV39h1 and targets
H3K9me3 and HP1 to the promoter of the parental Oct4 gene on
chromosome 17, leading to gene silencing in trans. Importantly,
this mechanism does not involve pairing of Oct4 sense and
pseudogene antisense RNAs. To this end, lncRNA sequence
determinants and evolutional importance for mOct4P4 pseudo-
gene lncRNA dependent silencing of Oct4 are not known.
Here, we show that the human POU5F1P3 pseudogene derived
lncRNA, hOCT4P3, is a functional homolog of the murine
Pou5f1P4 lncRNA in OVCAR-3 ovarian cancer cells, demon-
strating evolutionally constraint on pseudogene–lncRNA-medi-
ated epigenetic silencing of OCT4. Performing mOct4P4 lncRNA
pulldown experiments and a mOct4P4 lncRNA deletion analysis
we demonstrate that the RNA binding protein FUS and a 200
nucleotide mOct4P4/hOCT4P3 region are essential for Oct4/
OCT4 silencing in mouse and human cells. Binding of FUS to
endogenous, full length mOct4P4/hOCT4P3 lncRNAs allows
subsequent binding of SUV39H1 to the 200-nucleotide lncRNA
element, forming a silencing complex with target specificity for
the parental Oct4/OCT4 promoter. In experimental cell lines, the
200nt mOct4P4/hOCT4P3 lncRNA sequence element is sufficient
to guide SUV39H1 dependent Oct4/OCT4 silencing, even in the
absence of FUS.
We thus propose a model where FUS represents a licensing
factor that mediates the accessibility of the 200 nucleotide
mOct4P4/hOCT4P3 to SUV39H1 binding, thereby imposing
target specificity of the silencing complex towards the parental
Oct4/OCT4 gene promoter. Our data highlight the evolutionary
relevance of pseudogene lncRNA mediated control of parental
gene expression and the role of FUS in instructing the formation
of an epigenetic regulatory complex with target site specificity
defined by a lncRNA component.
Results
Conserved role of hOCT4P3 and mOct4P4 in silencing parental
gene expression. We recently demonstrated that the mouse
mOct4P4 lncRNA–SUV39H1 complex targets conserved pro-
moter elements of the ancestral Oct4 gene in trans, mediating
gene silencing during mESC differentiation. To support the
relevance of pseudogene lncRNA mediated epigenetic regulation
of parental gene expression we tested whether this mechanism is
conserved in human cells. To date, eight human POU5F1 pseu-
dogenes have been annotated in the human genome25. Similar to
mOct4P4, the human hOCT4P1, hOCT4P3, and hOCT4P4 pseu-
dogenes have an exon structure that is similar to the OCT4
mRNA and show 81%, 82%, and 82% overall sequence identity to
OCT4, respectively25. We previously showed that OCT4 is fre-
quently expressed in ovarian cancer cell lines and controls cancer
relevant pathways in OVCAR-3 cells15. This identifies OVCAR-3
ovarian cancer cells as ideal model system to validate conserva-
tion of pseudogene lncRNA mediated silencing of parental OCT4.
hOCT4P3 lncRNA displays high sequence similarity to mOct4P4
and reproduces nuclear localization pattern in a series of human
ovarian cancer cell lines (Fig. 1a, b)25.
Stable overexpression of hOCT4P3 in OVCAR-3 cells leads to
reduced OCT4 expression and downregulation of the self-renewal
transcription factors SOX2, NANOG, and KLF4, indicative for
impaired self-renewal circuits (Fig. 1c). Quantitative real-time
polymerase chain reaction (RT-PCR) experiments revealed that
hOCT4P3 and OCT4 transcript levels are 130- or 150-fold lower
than the housekeeping gene DAXX. This indicates that, although
present at low copy number, hOCT4P3 has an important role in
parental gene expression control (Supplementary Fig. 1a). To
demonstrate conservation of hOCT4P3 and mOct4P4 function we
used the CRISPR/dCas9–HAKRAB system to silence hOCT4P3
or mOct4P4 lncRNA expression in OCVAR-3 or mESC cells,
respectively.
We first generated mESC and human OVCAR-3 ovarian cancer
cell lines stably expressing an HA-tagged version of a catalytically
dead Cas9 version fused to the Kruppel associated box (dCas9-
HAKRAB; dCas9 empty cells). In a subsequent step dCAS9 empty
cells were stably transfected with an expression vector encoding
short-guide RNAs (sgRNAs) that locate dCas9–HAKRAB to the
promoter region of the Pou5f1P4/POU5F1P3 genes (dCAS9 s-
gOct4P4 mESCs or dCAS9 sgOCT4P3 OVCAR-3 cells). Expression
of dCAS9-HAKRAB and respective sgRNAs in experimental mESCs
and OVCAR-3 cells was validated by western blotting and RT-PCR
(Fig. 1d). We previously demonstrated that mOct4P4 is efficiently
upregulated during in vitro mESC differentiation17. Here, we used
embryoid body (EB) differentiation as model system to address the
impact of reduced mOct4P4 lncRNA expression on self-renewal and
early differentiation markers. dCAS9 empty and dCAS9 sgOct4P4
mESCs were cultivated in hanging drop cultures in the absence of
the self-renewal factor leukemia inhibitory factor (see “Methods”).
We found that upregulation of mOct4P4 expression was strongly
impaired during EB differentiation of dCAS9 sgOct4P4 mESCs
(Fig. 1e). This effect was paralleled by inefficient Oct4/OCT4 silen-
cing during 10 days of EB differentiation on the RNA and protein
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level (Fig. 1f, Supplementary Fig. 1b). Accordingly, we found
increased expression of self-renewal transcription factors Sox2,
Nanog, and Gdf3 and reduced expression of early differentiation
markers Fgf5 and Nestin (Fig. 1g). On the functional level,
dCAS9 sgOct4P4 embryoid bodies showed poor formation of
contractile cardiomyocyte structures, indicative for in vitro differ-
entiation defects (Fig. 1h, Supplementary Fig. 1c, Supplementary
Movies 1 and 2). Importantly, reduced expression of human
hOCT4P3 in dCAS9 sgOCT4P3 OVCAR-3 cells was paralleled
by increased expression of OCT4 at the RNA and protein level
(Fig. 1j, k). This effect was paralleled by reduced H3K9me3 at
conserved elements at the promoter of the parental OCT4 gene
(Fig. 1l). Based on our loss and gain of function experiment, we
conclude that hOCT4P3 recapitulates mOct4P4 function in human
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OVCAR-3 cells. Importantly, data from dCAS9–HAKRAB loss of
function models also demonstrate that endogenous mOCT4P4 and
hOCT4P3 lncRNAs have a suppressive action on the Oct4/OCT4
promoter in mESCs and OVCAR-3 cells.
Our results demonstrate the evolutionary conservation of
H3K9me3 dependent silencing of parental Oct4/OCT4 by mouse
and human mOct4P4 and hOCT4P3 sense lncRNAs. This further
implies the existence of defined lncRNA sequence elements
essential for site specific targeting of SUV39H1 to the Oct4/OCT4
promoter.
A deletion analysis identifies mOct4P4 lncRNA regions essen-
tial for Oct4 silencing. The MS2 RNA tagging system enabled
us to demonstrate that a mOct4P4 lncRNA–SUV39H1 complex
locates to the promoter of the ancestral Oct4 gene in trans17. In
order to identify lncRNA regions essential for mOct4P4 func-
tion we used a mESC cell line stably expressing a flag-tagged
version of the MS2 phage coat protein (MS2-flag mESCs) as
well as mOct4P4 deletion constructs that were tagged with 24
repeats of the MS2 RNA stem loop motif (Fig. 2a, Supple-
mentary Fig. 2a). To ensure nuclear localization, ectopically
expressed lncRNAs contained mOct4P4 regions corresponding
to the 5′ and 3′ UTR regions of parental Oct4, previously
shown to determine nuclear restriction of the endogenous
mOct4P4 lncRNA (Fig. 2a)17.
Established stable mESC cell lines displayed nuclear enrich-
ment of all mOct4P4-24xMS2 lncRNA versions (Fig. 2b, c).
Ectopic expression of full length mOct4P4-24xMS2 but also
deletion constructs with 200 or 400 nucleotides deletions
located at the mOct4P4 3′ terminus (Δ200, Δ400) efficiently
reduced Oct4 mRNA levels, as determined by quantitative RT-
PCR (Fig. 2d). Remarkably, constructs lacking 600 nucleotides
or more extended 3′ lncRNA regions were no longer able to
reduce Oct4 RNA expression (Δ600, Δ800, Δ994; 5′+ 3′;
Fig. 2d). These results were recapitulated by western blotting
using an OCT4 specific antibody (Fig. 2e). These data indicate
that functionally relevant mOct4P4 sequence elements are
anticipated to be located between position 984 and 1188 of the
mature mOct4P4 lncRNA.
We next evaluated the ability of mOct4P4-24xMS2 deletion
construct derived lncRNAs to (i) tether the flag-tagged MS2
phage coat protein to the Oct4 promoter and (ii) trigger increased
H3K9me3 levels at the Oct4 promoter. Anti-flag ChIP experi-
ments revealed that only MS2 RNA tagged full length, Δ200 and
Δ400 Oct4P4-24xMS2 lncRNAs were able to locate the flag-
tagged MS2 protein to the promoter of the ancestral Oct4 gene
and to trigger a local increase of H3K9me3 (Fig. 2f, g,
Supplementary Fig. 2b). Accordingly, MS2 RNA tagged Oct4P4
lncRNA versions that failed to suppress Oct4 expression (Δ600,
Δ800, Δ994; 5′+ 3′; Fig. 2d, e) were unable to locate flag-tagged
MS2 and H3K9me3 to the Oct4 promoter (Fig. 2f, g). Of notice,
ectopically expressed full length mOct4P4-24xMS2 lncRNA was
exclusively recruited to the Oct4 promoter but not to the
promoters of Daxx, H2Q10, Ceher1, Pp1r18, and Rab5A genes
that are localized up- and downstream of Oct4 on chromosome
17 (Supplementary Fig. 2c).
Together, this indicates that a 200 nucleotide sequence
spanning position 984–1183 of the mOct4P4 lncRNA has a
central role in orchestrating target site specific epigenetic
silencing of the ancestral Oct4 gene in trans.
A 200 nucleotide mOct4P4 region is sufficient to silence par-
ental gene expression. To directly test the importance of the 200
nucleotide mOct4P4 lncRNA region, we generated expression
constructs encoding MS2 RNA-stem loop tagged mOct4P4 that
lacks the relevant 200 nucleotide region (−200 bp -mOct4P4-
24xMS2) but also a construct encoding a MS2 RNA motif tagged
mOct4P4 lncRNA version that exclusively covers region 984–1183
(200 bp-mOct4P4-24xMS2) (Supplementary Fig. 2d). Both con-
structs contained the 5′ and 3′ mOct4P4 regions to ensure nuclear
localization of expressed lncRNAs (Fig. 3a). Stable MS2-flag
mESC clones expressed −200 bp-Oct4P4-24xMS2, 200 bp-
Oct4P4-24xMS2, or full length mOct4P4-24xMS2 lncRNAs as
nuclear restricted RNAs, as validated by quantitative RT-PCR
(Fig. 3a–c).
We next tested the impact of ectopic lncRNA expression on
H3K9me3 mediated silencing of parental Oct4. Quantitative RT-
PCR and western blotting revealed that −200 bp-mOct4P4-
24xMS2 expression failed to silence Oct4 expression. In contrast,
expression of the 200bp-mOct4P4-24xMS2 lncRNA version
mediated efficient suppression of ancestral Oct4, recapitulating
silencing by full length mOct4P4-24xMS2 lncRNA (Fig. 3d, e). In
line with this, ChIP experiments showed that the 200bp-
mOct4P4-24xMS2 lncRNA, but not the -200bp-mOct4P4-
24xMS2 - version recruited MS2-flag and H3K9me3 to the
parental Oct4 promoter (Fig. 3f, g).
We conclude that mOct4P4 pseudogene lncRNA contains two
regions with an essential role in silencing of the ancestral Oct4
gene: (i) 5′ and 3′ located sequences to ensure nuclear lncRNA
and (ii) region 984–1183 that directs H3K9me3 to the Oct4
promoter.
Fig. 1 Conserved function of hOCT4P3 and mOct4P4 lncRNAs. a Schematic representation of murine mOct4P4 and human hOCT4P3 pseudogenes. Length
of sequence elements and percentage of sequence homology are indicated. Gray boxes, sequences with homology to Oct4/OCT4 5′UTR; gray lines,
sequences with homology to Oct4/OCT4 3′UTR. A centrally located, 334-bp spliced fragment is exclusively present in mOct4P4 (29). b Subcellular
localization of hOCT4P3 in human Ovarian Cancer cell lines OVCAR-3, SKOV3, TOV-112D, and CAOV3 as determined by quantitative RT-PCR (qRT-PCR).
Shown values refer to the percentage of total RNA expression. c Quantitative RT-PCR analysis of hOCT4P3 (left panel), OCT4 and pluripotency marker
genes (right panel) in OVCAR-3 cells stably expressing hOCT4P3. Expression levels were normalized against ACTIN. d dCas9-HA-KRAB western blotting
analysis (top) and RT PCR analysis (bottom) of Oct4 pseudogene guide RNA (sgOct4P4, sgOCT4P3) in mouse embryonic stem cells (mESCs) (left panel)
and OVCAR-3 cells (right panel). ACTIN and Gapdh were used as control. e, f mOct4P4 lncRNA (e) and Oct4 (f) expression in self-renewing mESCs
(EB T0) and during 10 days of embryoid body (EB) differentiation (EB D3–D10). Expression levels were normalized to Gapdh. g qRT-PCR analysis of
self-renewal marker genes (left panel) or markers of early mESC differentiation (right panel) in dCas9/sgOct4P4 mESCs. Expression values were
normalized against gapdh. h Percentage of contractile cardiomyocyte structures in embryoid bodies (EBs) obtained from dCas9 or dCas9/sgOct4P4 cells.
i, j Quantitative RT-PCR showing hOCT4P3 lncRNA (i) and OCT4 (j) expression in dCas9 or dCas9/sgOCT4P3 OVCAR-3 cells. Expression values were
normalized using ACTIN. k OCT4 expression in knockdown dCas9 and dCas9/sgOCT4P3 OVCAR-3 cells as determined by western blotting. ACTIN was
used as control. Numbers represent OCT4/ACTIN ratio (dCAS9 empty was set “100”). l Chromatin immunoprecipitation (ChIP) analysis on the OCT4
promoter region in dCas9 and dCas9/sgOCT4P3 OVCAR-3 cells using H3K9me3 antibodies. Error bars represent standard deviation; Precise p values are
indicated; n number of independent experiments carried out.
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FUS interacts with endogenous mOct4P4 to allow parental
Oct4 gene silencing. In order to obtain additional insights into
the mechanism of mOct4P4 lncRNA mediated silencing of Oct4
we aimed to identify mOct4P4 lncRNA interacting proteins.
MS2-flag cells expressing full-length mOct4P4-24xMS2 and
control mESCs expressing only a 24xMS2 stem loop control
RNA were used to perform anti-flag RNA immunoprecipita-
tion (RIP) experiments. Obtained control and mOct4P4-
24xMS2 RNA-immunoprecipitates where run on denaturing
polyacrylamide gels. After Coomassie staining, protein bands
Fig. 2 mOct4P4 deletion analysis identifies the minimal RNA regions essential for lncRNA function. a Schematic representation of the mOct4P4-
24xMS2 deletion constructs. Gray boxes, sequences with homology to Oct4/OCT4 5′UTR; gray lines, sequences with homology to Oct4/OCT4 3′UTR; 334
bp lines represent centrally located, spliced fragment present in mOct4P4. 24xMS2 RNA stem loop motifs located at the 3′ end of mOct4P4 deletion
constructs are indicated. Arrows indicate the locations of RT-PCR primers used to amplify mOct4P4 deletion constructs. b Levels of ectopic expression of
mOct4P4-24xMS2 deletion construct (a) in mESCs, as determined by qRT-PCR. p Values relate to CTRL. c Subcellular localization of lncRNAs derived from
mOct4P4-24xMS2 lncRNA deletion constructs (a) in mESCs, as determined by qRT-PCR. Expression values are shown as percentage of total RNA levels.
p Values indicate significant nuclear versus cytoplasmic localization. d Oct4mRNA levels in mESCs with ectopic expression of mOct4P4 deletion constructs
(a), as determined by qRT-PCR. Expression values were normalized against gapdh. p Values relate to CTRL. e Representative image of OCT4 western
blotting analysis in mESC cells overexpressing mOct4P4 deletion constructs shown in (a). ACTIN was used as loading control. Numbers represents values
of OCT4 expression as mean of three independent experiments (control was set “100”). f, g anti-flag ChIP (f) and anti H3K9me3 ChIP (g) on the Oct4
promoter region in mESCs stably overexpressing 24xMS2 tagged deletion constructs shown in (a). qRT-PCR was performed to measure promoter
enrichment; p values relate to MS2-flag/24xMS2-CTRL. Precise p values are indicated; n number of independent experiments carried out.
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specifically appearing in eluates from mOct4P4-24MS2 RIPs
were cut out from the gel and subjected to mass spectrometry
(Fig. 4a). Flag-tagged MS2 as well as an additional set of pro-
teins were shown to be specifically over-represented in ana-
lyzed protein bands obtained from mOct4P4 lncRNA RIP
eluates (Fig. 4a, Supplementary Table 1a, Supplementary
Data 1). Given the reported involvement in gene silencing, we
focused our interest on the RNA and DNA binding protein
FUS28,29. In addition to transcriptional regulation, FUS has
been demonstrated to be involved in DNA repair, alternative
splicing, transcriptional regulation, RNA localization and stress
granules30. FUS translocation events and mutations have been
linked with liposarcoma and amyotrophic lateral sclerosis,
respectively31–33.
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Validation of RIP eluates by western blotting and RT-PCR
confirmed interaction of FUS with the full length mOct4P4
lncRNA (Fig. 4b). We were also able to detect mOct4P4-24xMS2
lncRNA as well as MS2-flag protein in the eluates from anti-FUS
RIP experiments, corroborating FUS–Oct4 pseudogene lncRNA
interaction (Fig. 4c).
We were next interested in evaluating whether FUS is required
for mOct4P4 lncRNA mediated silencing of Oct4. Transient
knockdown of FUS abolished mOct4P4 function, thus rescuing
OCT4 protein expression in mOct4P4-24xMS2 lncRNA over-
expressing mESCs (Fig. 4d). In line with this, ChIP experiments
revealed that FUS localizes to the Oct4 promoter in MS2-flag
mESCs overexpressing mOct4P4-24xMS2 (Fig. 4e).
We previously showed that the mOct4P4 lncRNA is essential to
maintain SUV39H1-dependent silencing of parental Oct4 in
primary mouse embryonic fibroblasts (pMEFs), indicating that
persistent localization of the mOct4P4 lncRNA at the Oct4
promoter is essential to maintain Oct4 silencing in differentiated
cells17.
To test whether mOct4P4 lncRNA is required for the
localization of FUS to the Oct4 promoter we performed ChIP
experiments in mOct4P4 lncRNA knock-down pMEFs. Our
results show that loss of endogenous mOct4P4 lncRNA displaced
FUS from the Oct4 promoter in pMEFs (Fig. 4f). Accordingly,
siRNA mediated depletion of FUS from pMEFs significantly
increased Oct4 mRNA expression, recapitulating the effect of
mOct4P4 knockdown on parental gene expression (Fig. 4g, h).
This effect was paralleled by increased expression of self-renewal
transcription factors Sox2, Nanog and Klf4 (Fig. 4i). We conclude
that FUS is essential for the initiation and maintenance of
mOct4P4 lncRNA mediated silencing of Oct4 in order to suppress
self-renewal circuits in differentiated mouse cells.
FUS facilitates binding of SUV39H1 to the mOct4P4 lncRNA.
mOct4P4 deletion constructs revealed that crucial regions for
Oct4P4 function are limited to a 200 nucleotide region, spanning
positions 984–1183 (Fig. 3a, d–g). To test whether this RNA
region interacts with SUV39H1 or FUS, we performed anti-
SUV39H1 and anti-FUS RIP experiments using MS2-flag mESC
clones overexpressing full length mOct4P4-24xMS2, −200 bp-
mOct4P4-24xMS2 or 200 bp-mOct4P4-24xMS2 constructs.
We found that the SUV39H1 protein co-immunoprecipitated
with the full-length mOct4P4-24xMS2 and 200 bp-mOct4P4-
24xMS2 lncRNAs, but not with −200 bp-mOct4P4-24xMS2
lncRNA (Fig. 5a). Interestingly, all types of ectopically expressed
mOct4P4 lncRNAs versions bound FUS in RIP experiments,
suggesting that FUS binds multiple mOct4P4 lncRNA regions
(Fig. 5b). In contrast, mOct4P4–SUV39H1 interaction critically
depends on the presence of the 200 nucleotide motif. Notably, we
did not find evidence for direct interaction of SUV39H1 and
FUS in co-immunoprecipitation assays (Supplementary Fig. 3a, b).
In addition, we did not find SUV39H1 peptides in our mass
spectrometry data from mOct4P4-24xMS2 lncRNA pull down
experiments (Supplementary Data 1). This is in line with a lack of
SUV39H1 in published data on the FUS interacting proteome34–38.
We conclude that direct SUV39H1–FUS interaction is not a pre-
requisite for silencing complex formation.
To study the functional interplay between FUS, SUV39H1, and
mOct4P4 in determining silencing complex function, we first
performed anti-FUS RIP in Suv39h1 knockdown MS2-flag
mESCs, stably overexpressing full-length mOct4P4-24xMS2 or
200 bp-mOct4P4-24xMS2 lncRNAs. We found that FUS interacts
with the full length mOct4P4-24xMS2 but also the 200 bp-
mOct4P4 lncRNA version in the presence and absence of
SUV39H1 (Fig. 5c, Supplementary Fig. 3c). Thus, SUV39H1 is
dispensable for FUS–mOct4P4 lncRNA interaction.
In a second step we transiently depleted FUS from
experimental cells and performed anti-SUV39H1 RIP experi-
ments followed by mOct4P4 specific RT-PCR. We found that
loss of FUS abolishes SUV39H1 binding to the full length
mOct4P4 lncRNA (Fig. 5d, Supplementary Fig. 3d). Strikingly,
binding of SUV39H1 to the 200 bp-mOct4P4-MS2 lncRNA
(mOct4P4 positions 984–1183) does not require FUS (Fig. 5d).
This indicates that binding of FUS to the full-length mOct4P4
lncRNA plays an important role in providing access for
SUV39H1 to the 200 nucleotide region. However, in the
context of reduced lncRNA sequence complexity of the 200 bp-
mOct4P4-MS2 construct, the critical 200 nucleotide region
appears to be directly accessible to SUV39H1, rendering the
action of FUS dispensable.
Oct4 mRNA and mOct4P4 lncRNA share high sequence
identity levels, raising the question as to whether SUV39H1 and
FUS may also interact with the endogenous Oct4 mRNA.
Importantly, RIP experiments using mESCs demonstrated that
under our experimental conditions SUV39H1 and FUS display
binding specificity towards mOct4P4 lncRNA but not Oct4 or
other mRNAs such as Sox2, Nanog, Gapdh, or Actin (Fig. 5e, f).
This demonstrates that sequence degeneration after mOct4P4
pseudogene formation resulted in the formation of binding sites
for FUS and SUV39H1, conferring a new biological function to
the mOct4P4 lncRNA. On the mechanistic level, our data indicate
that FUS has a critical role in supporting the interaction of
SUV39H1 with full length mOct4P4 lncRNA, suggesting that FUS
licenses the formation of a functional SUV39H1–mOct4P4
lncRNA complex in mESCs.
FUS mediates targeting of SUV39H1 by mOct4P4 lncRNA to
the Oct4 promoter. We next wished to investigate how lncRNA:
protein binding requirements translate into site specific targeting
of a SUV39H1 containing silencing complex to the Oct4 pro-
moter. We first validated whether FUS has a role in directing
mOct4P4 lncRNA and SUV39H1 to the Oct4 promoter.
Fig. 3 Silencing and promoter targeting is limited to a 200 nucleotide mOct4P4 lncRNA region. a Schematic representation of generated mOct4P4-
24xMS2 deletion constructs. Gray boxes, sequences with homology to Oct4/OCT4 5′UTR; gray lines, sequences with homology to Oct4/OCT4 3′UTR. 334
bp-spliced sequences are present in mOct4P4 and −200mOct4P4 sequences; deleted regions are indicated. White boxes indicate identified 200 nucleotide
mOct4P4 region. 24xMS2 RNA stem loop motifs at the 3′ end of mOct4P4 deletion constructs are indicated. Arrows indicate the locations of RT-PCR
primers. b qRT-PCR determining 200 bp-mOct4P4 and −200 bp-mOct4P4 expression levels in experimental mESCs. Expression values were normalized to
Gapdh. c Subcellular localization of lncRNAs derived from constructs in (a). Expression values are shown as percentage of total RNA levels, as determined
by qRT-PCR. d, e qRT-PCR (d) and western blot analysis (e) using mESCs ectopically expressing mOct4P4, 200 bp-mOct4P4, and −200 bp-mOct4P4
constructs. Oct4 expression values were normalized against Gapdh (d) or ACTIN (e). Shown numbers represent OCT4/ACTIN ratio as mean of three
independent experiments (control was set “100”) (e). f, g ChIP analysis of Oct4 promoter region in mESCs stably overexpressing indicated constructs and
using described antibodies. qRT-PCR was performed to measure promoter enrichment. Only mOct4P4 and 200 bp-mOct4P4 constructs localize to the Oct4
promoter (f) and drive H3K9me3 enrichment (g). Error bars represent standard deviation. Precise p values are indicated. n: number of independent
experiments carried out.
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Anti-flag ChIP experiments using chromatin from flag-MS2
mESCs expressing MS2-RNA tagged mOct4P4 lncRNA variants
demonstrate that transient knockdown of Fus abolishes the
recruitment of full length mOct4P4-24xMS2 but also SUV39H1
to the promoter of the ancestral Oct4 gene (Fig. 6a, b). In
line with this, ChIP revealed reduced H3K9me3 levels at
the Oct4 promoter and increased OCT4 protein expression
after siRNA mediated depletion of Fus from full length
mOct4P4 lncRNA overexpressing mESCs (Fig. 6c). This
demonstrates that FUS is essential for targeting the endogenous
mOct4P4 –lncRNA–SUV39H1 complex to the Oct4 promoter.
Importantly, performing anti-flag ChIP we found that siRNA
mediated depletion of Fus does not impair the localization of the
200 bp-mOct4P4-24xMS2 lncRNA version to the Oct4 promoter
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of experimental mESCs (Fig. 6d). Accordingly, 200 bp-mOct4P4
overexpression results H3K9me3 enrichment at the Oct4
promoter and a reduction of OCT4 protein expression in control
but also Fus knockdown mESCs (Fig. 6e, f). Thus, FUS is
dispensable for parental Oct4 silencing in the context of the
minimal sufficient 200 nucleotide mOct4P4 construct. However,
in context of the increased sequence complexity of endogenous,
full-length mOct4P4, FUS is essential to license the interaction
between SUV39H1 and mOct4P4 to allow the formation of a
silencing complex with Oct4 promoter target-specificity.
To further dissect requirements for Oct4 promoter targeting we
evaluated the relevance of SUV39H1 for targeting FUS and
mOct4P4 lncRNA to the parental Oct4 gene. Anti-FUS ChIP
experiments revealed that siRNA mediated depletion of Suv39h1
delocalizes FUS from the Oct4 promoter in mESCs ectopically
expressing full length mOct4P4 or the 200 bp-Oct4P4 lncRNA
(Fig. 6g). Importantly, siRNA mediated knockdown of Suv39h1
abrogates the localization of full lengthmOct4P4-24xMS2 but also
200 bp-mOct4P4-24xMS2 lncRNA versions to the promoter of the
ancestral Oct4 gene, as demonstrated by anti-flag ChIP. This
effect was linked with impaired imposition of H3K9me3 to the
Oct4 promoter and loss of parental Oct4 silencing in both
experimental cell lines (Fig. 6h–k, Supplementary Fig. 4).
These data highlight that FUS is essential to instruct the
loading of the repressive SUV39H1 HMTase to the critical 200
mOct4P4 lncRNA nucleotide region. This FUS dependent step is
central to program target specificity of SUV39H1, towards the
promoter of the parental Oct4 gene.
Functional conservation of a FUS–SUV39H1–OCT4 pseudo-
gene lncRNA silencing complex. After identifying critical players
for mOct4P4 function we set out to test whether all critical
mechanistic steps are conserved in human OVCAR-3 cells. We
first generated OVCAR-3 cell lines stably transfected with an
expression vector encoding 24xMS2 tagged full-length hOCT4P3
(hOCT4P3-24xMS2) or a 24xMS2 tagged hOCT4P3 lncRNA
region (200 bp-hOCT4P3-24xMS2) that corresponds to the
functional relevant 200 nucleotide mOct4P4 region (Fig. 7a,
Supplementary Fig. 5a). Functional experiments were carried out
after transiently transfecting experimental cell lines with an
expression vector encoding flag-tagged MS2.
In line with data from OVCAR-3 cells overexpressing untagged
hOCT4P3 (Fig. 1c), we found that ectopic hOCT4P3-24xMS2
expression reduced the expression of endogenous OCT4/OCT4
on the RNA and protein level (Fig. 7b, c). Anti-flag RIP revealed
interaction of MS2-flag with ectopically expressed hOCT4P3-
24xMS2 lncRNA, as demonstrated by RT-PCR (Fig. 7d).
ChIP experiments using anti-flag and anti-H3K9me3 specific
antibodies showed that the hOCT4P3-24xMS2 lncRNA localizes
the flag-tagged MS2-protein to the promoter of the ancestral
OCT4 gene, triggering a local increase in H3K9me3 (Fig. 7e, f). In
line with this, western blotting and RT-PCR on protein and RNA
fractions from anti-flag RIP eluates revealed that SUV39H1 and
FUS co-immunoprecipitate with full length hOCT4P3-24xMS2
lncRNA (Fig. 7g, h).
Anti-SUV39H1 RIP experiments in control MS2-flag and
MS2-flag/hOCT4P3-24xMS2 OVCAR-3 cells demonstrated that
siRNA-mediated depletion of FUS disrupts binding of SUV39H1
to the full-length hOCT4P3 lncRNA (Fig. 7i, Supplementary
Fig. 5b). In line with data from mESCs, transient depletion of FUS
disrupts pseudogene lncRNA mediated reduction of OCT4
expression in full-length hOCT4P3-24xMS2 lncRNA overexpres-
sing OVCAR-3 cells (Fig. 7j).
To validate the selective requirement of FUS for licencing full
length OCT4 pseudogene lncRNA function in human cells we
generated OVCAR-3 cells stably expressing a 24xMS2 tagged, 200
nucleotide hOCT4P3 region corresponding to the respective
sequence stretch in the mOct4P4 lncRNA (Fig. 7a, Supplementary
Fig. 5c). Importantly, we found that ectopic 200 bp-hOCT4P3
lncRNA expression recapitulates OCT4 silencing triggered by full
length hOCT4P3 lncRNA (Fig. 7k). In line with data from mESCs,
OCT4 silencing triggered by the 200 bp-hOCT4P3-24xMS2
lncRNA version was independent of FUS expression in
OVACR-3 cells (Fig. 7l, Supplementary Fig. 5d, e).
We conclude that all aspects of mOct4P4 function are
recapitulated by hOCT4P3 in human cells. This demonstrates
that pseudogene lncRNA dependent silencing of Oct4/OCT4
represents an evolutionary conserved mechanism to fine-tune the
expression of the parental Oct4/OCT4 gene.
On the mechanistic level we propose a model where FUS
binding to the endogenous mOct4P4/hOCT4P3 lncRNA plays an
important role in rendering the 200-nucleotide region accessible
for SUV39H1 binding. This step is essential to license the
formation of a SUV39H1 HMTase containing silencing complex
with programmed target specificity towards the parental
Oct4/OCT4 promoter (Fig. 8).
Discussion
Here, we investigate the molecular mechanism and evolutionary
conservation of Oct4/OCT4 pseudogene lncRNA mediated con-
trol of parental gene expression. Repression of hOCT4P3 or
mOct4P4 lncRNA expression in human OVCAR-3 or mESCs
using the CRISPR/dCas9-HAKRAB system resulted in loss of
H3K9me3 at the OCT4/Oct4 promoter and elevated OCT4/Oct4
expression levels (both at RNA and protein levels) in human or
Fig. 4 FUS is required for mOct4P4 lncRNA-mediated silencing of Oct4 in mESCs. a Silver stained protein gel of eluates obtained from mOct4P4-
24xMS2 anti-flag RIP experiments. mESCs expressing flag-MS2 and mOct4P4-24xMS2 were used. Indicated bands specifically elute from mOct4P4-
24xMS2 lncRNA. Protein identity was determined by mass spectrometry (Supplementary methods). b Anti-flag RIP using mESCs expressing MS2-flag/full
length mOct4P4-24xMS2 or 24xMS2 RNA control cells using anti-flag antibody. Agarose gel electrophoresis after quantitative RT-PCR demonstrates the
presence of mOct4P4-24xMS2 stem loop RNA (bottom panel). Detection of FUS and MS2-flag proteins by Western blotting (top and middle panel
respectively). Bands analyzed by mass spectrometry are indicated as numbers (1–6); complete data on protein identification is available in the provided
Supplementary Data 1. c Anti-FUS RIP using MS2-flag mESCs expressing full length mOct4P4-24xMS2 or 24xMS2 RNA control. Presence of FUS and flag-
MS2 in eluates was validated by western blotting (top and middle panel respectively). Quantitative RT-PCR followed by agarose gel electrophoresis verified
the presence of mOct4P4-24xMS2 in anti-FUS RIP experiments (bottom panel). d FUS and OCT4 western blotting using eluates from mOct4P4-24xMS2 or
24xMS2 mESCs transiently transfected with the indicated siRNAs. ACTIN was used as loading control. Numbers represent OCT4/ACTIN ratio as mean of
three independent experiments (24xMS2-CTRL siCTRL was set “100”). e, f ChIP analysis of Oct4 promoter region using an anti-FUS antibody in control or
FUS knockdown mESCs (e) or pMEFs (f). Eluates were analyzed by qRT-PCR. g Fus and mOct4P4 expression levels in pMEFs transiently transfected with
indicated siRNAs, as determined by qRT-PCR. Expression levels were normalized to Gapdh. h, i qRT- PCR analysis using pMEF cells subjected to siRNA-
mediated knockdown of mOct4P4 and Fus. Expression values for Oct4 (h) or self-renewal markers (i) were normalized against Gapdh. Error bars represent
standard deviation. Precise p values are indicated. n number of independent experiments carried out.
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mouse cells, respectively. This indicates functional conservation
of Oct4 pseudogene lncRNA mediated silencing of parental gene
expression in mouse and human cells. High overall sequence
identity and conservation of mOct4P4 function in human cells
suggested the existence of functionally relevant lncRNA regions.
A deletion analysis identified a 200-nucleotide region in
mOct4P4 and hOCT4P3 lncRNA that is required for targeting of
the lncRNA-SUV39H1 silencing complex to the promoter of the
ancestral Oct4/OCT4 gene, resulting in local H3K9 tri-
methylation. Binding of Oct4/OCT4 pseudogene lncRNA by
SUV39H1 is in line with studies demonstrating interaction of
SUV39H1 HMTases with pericentric RNAs, telomere repeat
containing RNA (TERRA), LINE1 L1MdA 5′UTR elements, SINE
B1 repeats and pRNAs of the rRNA cluster39–42. Direct
interaction of mOct4P4 lncRNA with SUV39H1 was recently
demonstrated by in vitro EMSA experiments (37). SUV39H1
HMTase–RNA-binding specificity is reported to be promiscuous
and characterized by low sequence specificity. This lead to the
hypothesis that the formation of lncRNA–SUV39H HMTase
complexes with defined epigenetic function may depend on
additional proteins or the presence of physiologically functional
RNA:chromatin templates43,44.
RNA pull-down experiments revealed a series of mOct4P4
lncRNA interacting proteins with a potential role in silencing
parental Oct4. Here, we demonstrate that the RNA binding
protein FUS has a critical role in Oct4/OCT4 lncRNA mediated
silencing of OCT4. Loss of FUS prevents the formation of a
full length mOct4P4/hOCT4P3 lncRNA–SUV39H1 silencing
Fig. 5 FUS licenses the formation of a SUV39H1–mOct4P4 lncRNA silencing complex. a Anti-SUV39H1 RIP in mESCs stably expressing mOct4P4-
24xMS2, 200 bp-mOct4P4-24xMS2 or −200 bp-mOct4P4-24xMS2 lncRNAs. Agarose gel electrophoresis after mOct4P4 specific quantitative RT-PCR (top
panel) and anti-SUV39H1 western blotting (bottom panel) on RIP eluates are shown. Anti-HA RIP was used as negative control. Arrow indicates primer
dimers. b Anti-FUS RIP in mESCs stably expressing 200 bp-mOct4P4-24xMS2 or −200 bp-mOct4P4-24xMS2 lncRNAs. Agarose gel electrophoresis after
mOct4P4 specific quantitative RT-PCR (top panel) and anti-FUS western blotting (bottom panel) on RIP eluates are shown. Anti-TUBULIN RIP was used as
negative control. c Anti-FUS RIP in mESCs stably expressing mOct4P4-24xMS2 or 200 bp-mOct4P4-24xMS2 lncRNAs. Agarose gel electrophoresis after
qRT-PCR confirmed FUS-Oct4P4 binding (top panel). Immunoprecipitation of FUS was validated by western blotting (bottom panel). d Anti-SUV39H1 RIP
in Fus knockdown mOct4P4-24xMS2 and 200 bp-mOct4P4-24xMS2 mESCs. mOct4P4 specific qRT-PCR followed by agarose gel electrophoresis is shown
(top panel). Presence of SUV39H1 in RIP eluates was validated by Western blotting (bottom panel). e, f Anti-SUV39H1 RIP (e) and anti-FUS RIP (f) in
mESCs stably expressing mOct4P4-24xMS2 or 24xMS2. Agarose gel electrophoresis after Oct4 mRNA or mOCT4P4 specific qRT-PCR is shown (top
panels). Anti-TUBULIN RIP was used as negative control. Immunoprecipitation of SUV39H1 (e) or FUS (f) was validated by Western blotting (bottom
panels e and f).
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complex, abrogating the initiation and maintenance of
Oct4/OCT4 silencing. Notable, FUS is dispensable for the func-
tion of the minimal sufficient mOct4P4/hOCT4P3 lncRNA ver-
sion (200 bp-mOct4P4; 200 bp-hOCT4P3). Thus, we conclude that
FUS does not have a central role in closing the Oct4/OCT4
promoter.
We propose that FUS is critical for the structuring the long
Oct4 pseudogene lncRNA template to allow the binding of
SUV39H1 to the 200-nucleotide region, thereby defining a spe-
cialized SUV39H1–lncRNA complex with selective target speci-
ficity towards the parental Oct4/OCT4 promoter. Importantly,
FUS and SUV39H1 do not bind to the Oct4 mRNA in RIP
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experiments. This demonstrates that the specific interaction with
FUS and the noncoding RNA-guided SUV39H1 HMTase repre-
sents a new biological feature of Oct4P4/OCT4P3 lncRNAs, that
was acquired during pseudogene evolution. Future experiments
will have to validate whether FUS has a more general role in
epigenetic gene regulation by controlling the association of
lncRNAs with epigenetic writers. In addition, the impact of
Oct4/OCT4 promoter associated pseudogene transcripts on
transcriptional initiation and Oct4/OCT4 promoter evasion
remains an interesting issue to be addressed.
In contrast to the selective requirement of FUS for full length
pseudogene lncRNA function, we found that SUV39H1 is
essential for targeting of both, the full-length and 200 nucleotide
mOct4P4/hOCT4P3 lncRNA versions to the Oct4/OCT4 pro-
moter. Thus, after FUS dependent silencing complex formation,
SUV39H1 and the 200 nucleotide mOct4P4/hOCT4P3 lncRNA
regions hold the information for selective targeting and epigenetic
silencing of the parental Oct4/OCT4 gene promoter.
The requirement of FUS as critical factor to license endogenous
mOct4P4/hOCT4P3 lncRNA function may also represent a reg-
ulatory mechanism that restricts pseudogene-lncRNA mediated
silencing to a defined biological context. Along these lines, PRMT1
dependent arginine methylation of FUS was recently shown to
prevent the interaction with the CCND1 gene promoter-associated
noncoding RNA-D (pncRNA-D), thereby blocking the repression of
the HAT activity of the CBP/p300 HAT complex28,29. Addressing
post-translational modifications of FUS may identify windows of
mOct4P4/hOCT4P3 function in development and disease.
In addition to mOct4P4/hOCT4P3 also other pseudogene
derived lncRNAs, such as DUXAP8 and DUXAP10 have been
shown to interact with epigenetic writers12,45,46. However,
DUXAP lncRNAs rather act as general scaffold for epigenetic
regulatory complexes that do not selectively target the parental
DUXA gene. In contrast, pseudogene PTENP1 antisense tran-
scripts drive DNMT1 dependent silencing of the parental PTEN
gene by paring with the 5′UTR of the nascent, sense PTEN
RNA9,11. We experimentally validated that Oct4 and mOct4P4 are
exclusively transcribed in sense orientation, thus excluding
extended RNA:RNA interactions17. Thus, mOct4P4 and
hOCT4P3 represent pseudogene sense lncRNAs that use a con-
served mechanism to target and remodel the chromatin status of
the parental gene promoter, located on a different chromosome.
Altogether, we propose a four-step model: (i) FUS binds
mOct4P4/hOCT4P3 to (ii) allow SUV39H1 binding to the 200
nucleotide region, followed by (iii) sequence specific targeting of
the Oct4/OCT4 promoter, resulting in (iv) increasing local
H3K9me3 and HP1 levels and Oct4/OCT4 silencing (Fig. 8). The
specific binding of SUV39H1 to H3K9me3 is anticipated to
contribute to the maintenance of local heterochromatin structure
at the Oct4/OCT4 promoter40,41.
Silencing of Oct4/OCT4 in trans may depend on complex long-
range chromatin interaction of involved (pseudo)gene–loci,
alternative DNA structures or the recruitment of additional fac-
tors. Elucidating mechanisms that functionally connect pseudo-
genes loci with ancestral genes will provide new insights into the
power of pseudogenes encoded lncRNAs in fine-tuning the
expression of ancestral genes in development and disease.
Methods
Cell culture. Feeder independent mESCs were cultured on 0.2% gelatin-coated
plates using mESC self-renewal medium composed by Dulbecco’s modified Eagle’s
medium (DMEM) (Lonza) supplemented with 15% knockout serum replacement
(Gibco), 1% nonessential amino acids (Gibco), 1 mM sodium pyruvate (Gibco),
0.1 mM β-mercaptoethanol, 1% penicillin/streptomycin (Lonza) and 1000 U/ml
mouse leukemia inhibitory factor47. OVCAR-3 cells were obtained from ATCC
and cultured in RPMI-1640 medium (Lonza) supplemented with 20% (v/v)
fetal bovine serum (FBS) (Lonza), insulin (10 μg/ml; I9278,Sigma) and 1% (v/v)
penicillin/streptomycin (Lonza). Primary mouse embryonic fibroblasts (pMEFs)
were generated in house from 13.5 d.p.c. C57BL/6 mouse embryos. pMEFs were
maintained in culture in DMEM (Lonza) supplemented with 10% (v/v) FBS
(Lonza) and 1% (v/v) penicillin/streptomycin (Lonza). Cell lines were maintained
as monolayers at 37 °C in a humidified 5% CO2 atmosphere.
mESCs differentiation was obtained with a DMEM supplemented with 15% ES
cell certified serum (Invitrogen), 1% non-essential amino acids (Gibco), 1 mM
sodium pyruvate (Gibco), 1% L-glutamine (Invitrogen), 0.1 mM β-
mercaptoethanol, and 1% penicillin/streptomycin (Invitrogen). EBs were generated
by cultivating 300 cells in hanging drops culture for 3 days. Subsequently, EBs were
transferred to a low-attachment 24-well plates (Euroclone) and grown in
suspension for the indicated days. Alternatively, embryoid bodies were transferred
to adherent cell culture dishes and cultivated for the indicated time periods to
obtain contractile cardiomyocyte structures. All used cells were tested for
mycoplasma contamination in regular intervals.
Viral transduction and generation of stable cell lines. Retroviral vectors such as
pLPC-24xMS2, pLPC-mOct4P4-24xMS2, pLPC-mOct4P4-deletion constructs
pLPC-200 bp-mOct4P4-24xMS2, pLPC-(−200 bp)-mOct4P4-24xMS2, pPLC-
hOCT4P3-24xMS2, pLPC-200bp-hOCT4P3-24xMS2, and pMSCV-HA-MS2-Flag
were packaged using 293GP cells. Forty-eight hours post transfection 10 ml of
supernatants were harvested, filtered through a 0.45 µm filter and used to infect
OVCAR-3 or ES cells in presence of polybrene. Twenty-four hours later medium
was replaced with selection medium to obtain stable cell pools. Lentiviral vectors
pLX-sgOCT4P3, pLX-sgOct4P4, and pHAGE-EF1α-dCas9-HA-KRAB (Addgene
plasmid #50919) were packaged using 293T cells. Ten millilitre of supernatants
were harvested, filtered through a 0.45 µm filter and used to infect OVCAR-3 or ES
cells in presence of polybrene. Twenty-four hours later medium was replaced with
selection medium to obtain stable cell pools. ES were transduced with retroviral
vectors; OVCAR-3 cells with lentiviral and retroviral vectors. Cell lines infected
with pLPC and pHAGE vectors were maintained in culture with 3 µg/mL of
Puromycin and pMSCV and pLX vectors with 4 µg/mL of Blasticidine.
Transient transfection of plasmids and siRNAs. Transient transfections of
plasmids were performed using TransIT®-LT1 transfection reagent (#MIR-2300,
Mirus). Transient transfection of siRNA was performed using Lipofectamine
RNAiMAX reagent (Invitrogen) according to manufacturer’s suggestions. Fol-
lowing siRNAs were used for transient siRNA experiments: Fus: GCAA-
CAAAGCUACGGACAA (Eurofins Genomics); Suv39h1:
CCAAUUACCUGGUGCAGAA (Thermo Scientific Dharmacon); mOct4P4
GAGCAUGAGUGGAGAGGAA (Thermo Scientific Dharmacon). Control siRNA
Fig. 6 SUV39H1 and the 200 bp-mOct4P4 region are sufficient for paternal gene silencing. a–c ChIP analysis of the Oct4 promoter region in control,
mOct4P4-24xMS2 or 24xMS2 overexpressing mESC lines, transfected with the indicated siRNAs. Antibodies used for RIP are shown. Quantitative RT-PCR
was performed to evaluate enrichment of markers at the Oct4 promoter. d, e ChIP analysis of Oct4 promoter region in 24xMS2-CTRL, mOct4P4-24xMS2,
and 200 bp-mOct4P4-24xMS2 mESCs after siRNA mediated depletion of Fus. Quantitative RT-PCR was performed to measure abundance of flag-MS2 (d)
and H3K9me3 (e) at the Oct4 promoter. f OCT4 expression levels in 24xMS2-CTRL, mOct4P4-24xMS2 and 200 bp-mOct4P4-24xMS2 mESCs after Fus
knockdown. ACTIN was used as loading control. Numbers represent OCT4/ACTIN ratio (24xMS2-CTRL siCTRL was set “100”). g ChIP analysis of FUS
abundance at the Oct4 promoter region in control, mOct4P4-24xMS2 or Suv39h1 knockdown mOct4P4-24xMS2 overexpressing mESC lines. h, i ChIP
analysis of Oct4 promoter region in control, mOct4P4-24xMS2 and 200 bp-mOct4P4-24xMS2 mESCs after siRNA mediated depletion of Suv39h1.
Quantitative RT-PCR was performed to measure enrichment of flag-MS2 (h) or H3K9me3 (i) at the Oct4 promoter. j, k Oct4 specific qRT-PCR (j) and
OCT4 western blotting (k) of Suv39h1 knockdown control, mOct4P4-24xMS2 and 200 bp-mOct4P4-24xMS2 mESCs. RNA expression values were
normalized against Gapdh; ACTIN was used as loading control in western blotting experiments. Numbers represents OCT4/ACTIN ratio (24xMS2-CTRL
siCTRL was set “100”). Error bars represent standard deviation. Precise p values are indicated. n number of independent experiments carried out.
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was used as a negative control: Non-Targeting siRNA#1, TAGCGACTAAACA-
CATCAA (Thermo Scientific Dharmacon).
RNA immunoprecipitation. Experimental cells were scraped in RIPA buffer (50
mM Tris-Cl, pH 7.5, 1% Nonidet P-40 (NP-40), 0.5% sodium deoxycholate, 0.05%
sodium dodecyl sulfate, 1 mM EDTA, 150 mM NaCl) and supplemented with
protease inhibitors (Complete, Roche) and RNaseOUT (Invitrogen). After incu-
bation at 4 °C for 20 min, cell lysates were centrifuged. The supernatant was
precleared for 1 h at 4 °C with protein A/G PLUS-Agarose (protein A/G PLUS-
Agarose—sc-2003; Santa Cruz Biotechnology supplemented with yeast tRNA.
0.1 mg/mL). The precleared supernatant was incubated overnight at 4 °C with
rabbit polyclonal anti-TLS/Fus (ab23439, abcam), mouse monoclonal anti-
KMT1A/Suv39h1 (2.5 mg/ml, ab12405, Abcam) or mouse monoclonal anti-FLAG
M2, clone M2 (2.5 mg/ml; F1804; Sigma) antibodies. RNA–protein complexes were
recovered with protein A/G PLUS-Agarose beads and were washed six times in
RIPA buffer. An aliquot of beads containing immunoprecipitated samples were
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saved for western blotting analysis. Remaining beads were used to obtain immu-
noprecipitated RNA that was analyzed by qRT-PCR. A mouse monoclonal anti-
HA antibody, clone HA-7 (2.5 mg/ml, Sigma H9658) was used as negative control
for immunoprecipitation.
Statistics and reproducibility. A one-tailed t test was performed to calculate
p values and statistical significance was set at p < 0.05. Each finding was confirmed
by three independent biological replicates, unless differently specified. Error bars
represent standard deviation.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
All data generated or analyzed during this study are included in this published article and
related Supplementary information files. Source data of blots and gels are shown in
Supplementary Fig. 6.
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cells after siRNA mediated depletion of FUS. Top panel, hOCT4P3 specific qRT-PCR followed by agarose gel electrophoresis; bottom panel, anti-SUV39H1
western blotting using RIP eluates. j OCT4 and FUS expression in control and hOCT4P3-24xMS2 overexpressing OVCAR-3 cells after siRNA-mediated
depletion of FUS, as determined by qRT-PCR (left panel) and western blotting (right panel). ACTIN was used as loading control. Numbers represent
OCT4/ACTIN ratio as mean of three independent experiments (24xMS2-CTRL siCTRL was set “100”). k OCT4 expression in 24xMS2-CTRL, hOCT4P3-
24xMS2 and 200 bp-hOCT4P3-24xMS2 OVCAR-3 cells as determined by qRT-PCR (left panel) and western blotting (right panel). ACTIN was used to
normalized OCT4 expression values in qRT-PCR and western blotting experiments. Numbers represent OCT4/ACTIN ratio (24xMS2-CTRL was set “100”)
(right panel). l OCT4 expression levels in 24xMS2-CTRL, OCT4P3-24xMS2, and 200 bp-hOCT4P3-24xMS2 OVCAR-3 cells under control or FUS
knockdown condition, as determined by qRT-PCR (left panel) and western blot (right panel). ACTIN was used as loading control. Numbers represent
OCT4/ACTIN ratio as mean of three independent experiments (24xMS2-CTRL siCTRL was set “100”). Error bars represent standard deviation. Precise
p values are indicated. n number of independent experiments carried out.
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mOct4P4/hOCT4P3 to provide access for SUV39H1 to 200 nucleotide
lncRNA region (highlighted in green). Binding of mOct4P4/hOCT4P3
lncRNA to SUV39H1 creates a silencing complex with target specificity for
the promoter of the ancestral Oct4/OCT4 leading to repression of parental
Oct4/OCT4 by creating local H3K9me3 containing heterochromatin.
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